BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.verified

BCT.TO

Price:

$15.8

Market Cap:

$21.50M

BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development a...[Read more]

Industry

Biotechnology

IPO Date

2012-08-13

Stock Exchange

TSX

Ticker

BCT.TO

The Enterprise Value as of December 2025 (TTM) for BriaCell Therapeutics Corp. (BCT.TO) is 9.04M

According to BriaCell Therapeutics Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.04M. This represents a change of -94.28% compared to the average of 158.00M of the last 4 quarters.

BriaCell Therapeutics Corp. (BCT.TO) Historical Enterprise Value (quarterly & annually)

How has BCT.TO Enterprise Value performed in the past?

The mean historical Enterprise Value of BriaCell Therapeutics Corp. over the last ten years is 317.17M. The current 9.04M Enterprise Value has changed 184.99% with respect to the historical average. Over the past ten years (40 quarters), BCT.TO's Enterprise Value was at its highest in in the July 2016 quarter at 2.99B. The Enterprise Value was at its lowest in in the July 2021 quarter at -56629006.06.

Quarterly (TTM)
Annual

Average

317.17M

Median

172.05M

Minimum

68.38M

Maximum

1.02B

BriaCell Therapeutics Corp. (BCT.TO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BriaCell Therapeutics Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 513.93%

Maximum Annual Enterprise Value = 1.02B

Minimum Annual Increase = -88.00%

Minimum Annual Enterprise Value = 68.38M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024121.88M-88.00%
20231.02B4.49%
2022972.10M454.39%
2021175.35M156.41%
202068.38M-39.58%
2019113.19M-34.82%
2018173.66M7.17%
2017162.04M-18.53%
2016198.91M16.70%
2015170.44M513.93%

BriaCell Therapeutics Corp. (BCT.TO) Average Enterprise Value

How has BCT.TO Enterprise Value performed in the past?

The current Enterprise Value of BriaCell Therapeutics Corp. (BCT.TO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

703.25M

5-year avg

470.70M

10-year avg

317.17M

BriaCell Therapeutics Corp. (BCT.TO) Enterprise Value vs. Peers

How is BCT.TO’s Enterprise Value compared to its peers?

BriaCell Therapeutics Corp.’s Enterprise Value is less than Resverlogix Corp. (30.32M), less than Perimeter Medical Imaging AI, Inc. (14.19M), less than Rapid Dose Therapeutics Corp. (25.91M), less than Gemina Laboratories Ltd. (17.07M), less than Pangenomic Health Inc. (9.25M), less than Telescope Innovations Corp. (18.17M), less than Greenway Greenhouse Cannabis Corporation (36.02M), less than Hemostemix Inc. (19.07M), less than Izotropic Corporation (22.81M), less than Microbix Biosystems Inc. (27.97M),

Build a custom stock screener for BriaCell Therapeutics Corp. (BCT.TO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BriaCell Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BriaCell Therapeutics Corp. (BCT.TO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BriaCell Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is BriaCell Therapeutics Corp.'s Enterprise Value?

What is the highest Enterprise Value for BriaCell Therapeutics Corp. (BCT.TO)?

What is the 3-year average Enterprise Value for BriaCell Therapeutics Corp. (BCT.TO)?

What is the 5-year average Enterprise Value for BriaCell Therapeutics Corp. (BCT.TO)?

How does the current Enterprise Value for BriaCell Therapeutics Corp. (BCT.TO) compare to its historical average?